Background/Aims: Podocyte injury, especially podocyte apoptosis, plays a major role in earlystage diabetic nephropathy (DN). Swiprosin-1, also known as EF hand domain containing 2 (EFhd2), is a Ca 2+ -binding protein in different cell types. However, the function of swiprosin-1 in podocytes remains unknown. Methods: The expression and distribution of swiprosin-1 were investigated in the mouse renal glomerulus and conditionally immortalized mouse podocyte cell line MPC-5. The expression of swiprosin-1 was also detected in streptozotocin (STZ)-treated mice and MPC-5 cells treated with high glucose (HG). Nephrin and podocin were detected by immunohistochemistry and immunofluroscence. Collagen IV, transforming growth factor-β (TGF-β) and fibronectin mRNA expressions were assayed by real-time PCR. Apoptotic proteins and phosphorylation of p38 mitogen-activated protein kinase (MAPK) were detected by immunoblotting. Results: Swiprosin-1 was found to be expressed in podocytes of the mouse glomerulus and MPC-5 cells. Swiprosin-1 expression was increased in STZ-treated mice and MPC-5 cells treated with HG. In Swiprosin-1 -/-diabetic mice, kidney/ body weight, urinary albumin, podocyte foot process effacement and glomerular basement membrane thickening were attenuated; the downregulation of nephrin and podocin expression in the glomerulus was inhibited; and the upregulation of collagen IV, TGF-β and fibronectin mRNA expression in the renal cortex was ameliorated as compared with those in diabetic swiprosin-1 +/+ mice. In addition, the increased apoptosis of podocytes, proapoptotic protein expression and p38 phosphorylation in Swiprosin-1 -/-diabetic mice were inhibited as compared with those in diabetic swiprosin-1 +/+ mice. Knockdown of swiprosin-1 in MPC-5 cells
Introduction
Diabetic nephropathy (DN) is the most common cause of end-stage renal disease worldwide, mainly characterized by extra-cellular matrix (ECM) accumulation, glomerular basement membrane (GBM) thickening and podocyte injury [1] [2] [3] . ECM accumulation and GBM thickening used to be considered as the primarily important mechanisms in the pathogenesis of DN. However, evidence in recent years indicates that podocytes are critical cells for maintaining the renal filtration barrier and preventing albuminuria, playing an important role in the development of renal diseases [4] [5] [6] . Podocyte damage, such as alterations in the structure of podocytes or loss of podocytes will affect the integrity of the glomerular filtration barrier, resulting in proteinuria, thus promoting the progression of DN [7, 8] . Accumulating evidence indicates that DN is more like a "podocyte disease" [9] [10] [11] . Some clinical studies [12, 13] showed that the number of podocytes was reduced by detachment, or apoptosis as the primary reason. As podocytes are terminally differentiated epithelial cells and located in the glomerular basement membrane, their apoptosis is associated with their inability to be replaced or regenerated, ultimately resulting in glomerulosclerosis. Although podocyte apoptosis plays a major role in early-stage DN, the underlying molecular pathogenesis remains unclear.
Swiprosin-1, also known as EF hand domain containing 2 (EFhd2), was initially identified as a novel protein in human CD8 + lymphocytes [14] , and subsequently in immature, resting or activated B cells [15] [16] [17] , macrophages and natural killer cells [18, 19] , and non-lymphoid tissues such as the brain, spleen, lung, liver and heart [17, 20, 21] . In murine B cells, ectopic expression of swiprosin-1 was found to enhance spontaneous and B-cell receptor induced apoptosis [16, 22] . In addition, swiprosin-1 was found to be involved by signaling cascades involving Ca 2+ [19, 20] , protein kinase C, and nuclear factor-κB [23] . Also, swiprosin-1 was reported to be involved in the process of caspase-9-protein complexes in non-small cell lung cancer (NSCLC) cells and may promote caspase-9 activation, which may be linked to cell apoptosis [24] .
In a study we conducted previously we could show that swiprosin-1 was also expressed in the mouse brain, heart, stomach and kidney [25] . Here, we further found that swiprosin-1 was predominantly expressed in podocytes of the mouse glomerulus and was up-regulated in the kidney of 8-week-old diabetic mice. These results indicated that swiprosin-1 expressed in glomerular podocytes might be involved in early-stage DN. Considering that swiprosin-1 was also shown to be involved in apoptosis, we hypothesized that swiprosin-1 might be a crucial protein in podocyte apoptosis in early-stage DN.
In this study, we firstly sought to investigate whether and how swiprosin-1 promoted podocyte apoptosis in vivo and in vitro in the glomerulus of diabetic mice and conditionally immortalized mouse podocyte cell line MPC-5 treated with high glucose (HG); further explore the signaling pathway of swiprosin-1 in early-stage DN; and finally examine whether p38 mitogen-activated protein kinase (MAPK) was activated by swiprosin-1 in vivo and in vitro.
Materials and Methods

Materials
The main materials used in this study were streptozocin (STZ) (Sigma-Aldrich, St Louis, MO, USA); Cell Counting Kit-8 (CCK-8) and JC-1 mitochondrial membrane potential assay kit (Beyotime, Shanghai, China); Lipofectamine 2000 reagent (GenePharma, Shanghai, China); antibodies against swiprosin-1 and podocin (Santa Cruz, Dallas, TX, USA); nephrin (Boster, Wuhan, China); cleaved caspase-8，Wilms Tumor 1 (WT-1, Novus biochemisry, Colorado, America); cleaved caspase-3 (Abcam, Cambridge, UK); cleaved caspase-9, Bax, Bcl-2, cytochrome C, total p38 and phospho-p38 (Cell Signaling Technology, Boston, MA, USA); tubulin (Beyotime, Shanghai, China); SB203580(Selleck Chemicals, Texas, America); BCA protein quantification kit (Bi-yun-tian, Shanghai); Trizol reagent, PrimeScript RT Master Mix Perfect Real Time kit and FastStart Universal SYBR Green Master (Invitrogen, Carlsbad, CA, USA); type I collagen (Biochrom, Berlin, Germany); mouse recombinant interferon (IFN-γ) (Immugenex, Los Angeles, CA); RPMI 1640, fetal bovine serum (FBS) (GIBCO, Grand Island, NY); mannitol (Beijing Dingguo Changsheng Biotechnology, Beijing, China). All chemicals were purchased from Sigma-Aldrich. Animals C57BL/6J male mice weighing 18-22 g were purchased from the SLRC Laboratory Animal Lid (Shanghai, China).
Swiprosin-1 knockout mice were generated as described previously [16] . Recombineering was used to generate a gene targeting construct from a bacterial artificial chromosome (BAC) containing the swiprosin-1 gene (C57Bl/6J inbred strain). E14 ES cells were transfected with this construct, and successfully targeted ES cells were injected into C57Bl/6J blastocysts. Mice bearing this targeted allele of exon 2-4 deletion in the germline were bred to generate swiprosin-1 −/− mice. All mice were kept under an automated 12 h/12 h dark-light cycle at a controlled temperature of 22 °C±2 °C and relative humidity of 50-60% and allowed free access to standard dry diet and tap water. All animals received humane care. All the experimental procedures were performed in accordance with the guidelines of the Second Military Medical University (Shanghai, China) for health and care of experimental animals.
Diabetic models and specimen collection
Firstly, 20 C57BL/6J male mice were equally randomized to two groups: control group (CON) and diabetic group (DM). [26] , and mice in control groups received the sodium-citrate vehicle correspondingly. After 72 h, diabetes was confirmed in STZ-treated mice by measuring plasma glucose via the tail vein (random blood glucose value >16.7 mM). After 8 weeks, all mice were killed to harvest the kidneys.
Serum cystatin C assay
Serum cystatin C is known as an ideal marker of the glomerular filtration rate (GFR). ELISA for mouse serum cystatin C assay (Abnova, Neihu District. Taipei City) was used according to the manufacturers' protocol.
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siRNA transfection and treatment
SiRNA transfection was performed as described previously [27] . Cells were seeded at 2 × 10 5 /well in 6-well plates, incubated overnight at 37 °C, and then transfected with 75 pM siRNA (GenePharma, shanghai, China), Opti-MEM I Reduced Serum Medium and Lipofectamine 2000 complex. The sequences are as follows: siRNA-swiprosin-1(si-Swi), 5'-GCCGCUUUGAGGAAGAGAUTT-3', and 5'-AUCUCUUCCUCAAAGCGGCTT-3'; siRNA-p38 (si-p38), 5'-GGUCACGGAGGAAUUCAATT-3' and 5'-UUGAAUUCCUCCAGUGACCTT-3'; negative control siRNA (Con), 5'-UUCUCCGAACGUGUCACGUTT-3' and 5'-ACGUGACACGUUCGGAGAATT-3'. After 6 h, transfected cells were washed, cultured for 24 h in complete medium, stimulated with HG or NG for 48 h, and finally harvested for analysis.
Lentivirus construction and preparation CDS sequence (residues 54-776 in the murine Swiprosin-1 cDNA sequence, GenBank accession number NM_025994.3) was synthesized to construct LV-GFP as negative control. The recombinant lentivirus expressing swiprosin-1 full-length coding sequence (LV-Swi) was produced by Shanghai Innovation Biotechnology Co., Ltd (Shanghai, China). The virus was concentrated by ultracentrifugation and titred by infection of confluent 293T cells.
Cell viability assay
Cell viability was indirectly evaluated by CCK-8 assay. Differentiated MPC-5 cells were seeded in a 96-well plate at a density of 2 × 10 3 /well. After 48 h incubation in medium containing different concentrations of D-glucose (5.5-33 mM), cells were treated with 10 μL CCK-8 solution for 1 h at 37 °C. Optical density (OD) was measured at 450 nm with a microplate reader. The result was calculated as the mean value of five wells for each group, and the assay was performed in triplicate.
Protein extraction and immunoblotting
Immunoblotting was detected as described previously [28] . Briefly, MPC-5 cells or kidney tissues were washed with cold phosphate buffer saline (PBS), and then lysed in protein extraction reagent containing protease and phosphatase inhibitor cocktail. The mixture was centrifuged at 12, 000 g for 15 min at 4 °C, and the protein concentration of the supernatant was determined by Bradford method. After being mixed with loading buffer, the sample was boiled at 98 °C for 5 min. An equal amount of protein was separated by 12.5% (w/v) sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to the nitrocellulose membrane, which was blocked for 3 h at room temperature with the blocking reagent and then incubated with the primary antibodies overnight at 4 °C. Tubulin was diluted at 1:5000, and the other antibodies were diluted at 1:1000. Then the membrane was incubated with corresponding secondary antibodies (1:5000 dilution) for 30 min at room temperature. Odyssey infrared imaging system (LI-COR, Lincoln, NE, USA) was used to analyze the results. All immunoblotting experiments were repeated at least three times.
Immunohistochemical staining
The kidneys were perfused with ice cold saline before being collected from the animals. The renal tissues were formalin-fixed, paraffin-embedded and cut into 4-5 μm sections. Then sections were deparaffinized and rehydrated. To unmask antigens, the slides were boiled at 100 °C for 10 min in 10 % citrate buffer (pH 6.0). After blocking with the buffer (PBS, 2% BSA, 10% FBS) for 1 h, the slides were incubated with antibodies against swiprosin-1(1:100) and nephrin (1:100) overnight at 4 °C, and then incubated with secondary antibody (1:100). The immunoreaction products were developed using diaminobenzidine (DAB) as the chromogen, with standardized development times. The sections were examined by microscopy. For quantitative analysis, 3-6 glomeruli per group of per animal in each experiment were analyzed. Nephrinpositive cells were quantified by counting five different fields at 400× magnification in each section.
Electron microscopy
Electron microscopy was performed as described previously [29] . The renal tissues from the mice in each group were perfused with ice cold saline before collection, then rapidly cut into small (1-3 mm 3 ) pieces and fixed in 2.5 % glutaraldehyde. The pieces were thin sectioned and collected in grids. Two grids for each animal were prepared and five animals per group were analyzed. The ultrastructural features of podocytes were observed under the electron microscope.
Immunofluorescence staining
Immunofluorescence staining of the kidney specimens was performed as described previously [30] . The kidneys were perfused with ice cold saline before being collected from the animals. The slides were fixed, incubated with antibodies swiprosin-1 (1:100), WT-1 (1:100) and podocin (1:100) overnight at 4 °C, washed, incubated with corresponding Alexa Fluor 488 or 549 secondary antibody (1: 200; Molecular Probes, Eugene, OR, USA) in dark for 2 h at room temperature, mounted, and observed under a fluorescence microscope.
For immunofluorescence staining of differentiated MPC-5 cells, samples were fixed with 4 % paraformaldehyde in PBS for 10 min, blocked in 0.4 % Triton-X-100/2% bovine serum albumin (BSA) for 1 h, incubated with primary antibodies for swiprosin-1 and nephrin in 1% BSA/PBS at 37 °C for 2 h, washed, incubated with fluorescence conjugated secondary antibodies for 1 h at 37 °C in dark, washed again, dried, and incubated with DAPI. The images were analyzed by fluorescence microscopy.
TUNEL assay
The apoptosis rate of cells in the mouse renal cortex and cultured podocyte cells was measured using a One
Step TUNEL Apoptosis Assay Kit (KeyGEN BioTECH, Nanjing, China) according to the manufacturer's instructions. Apoptosis was defined as the presence of TUNEL-positive podocytes within glomeruli. The mean percentage of TUNEL-positive podocytes in podocytes of per glomerulus in the formalin-fixed renal section was determined by examining 6-8 glomeruli from the group studied. Images were analyzed by fluorescence microscopy (Olympus Corporation, Tokyo, Japan) or by confocal microscopy (Leica DMLB, Wetzlar, Germany).
Apoptosis analysis by flow cytometry
Cell apoptosis was analyzed using Annexin V-FITC apoptosis kit (eBioscience, Santiago, CA, USA) or Alexa Fluor@647 Annexin V apoptosis kit (using for lentivirus transfected cells, Biolegend, San Diego, CA). As described previously [31] , total cells (1 × 10 6 cells/well) were collected through centrifugation and then resuspended in 500 μL binding buffer. Then, 100 μL solution containing 1 × 10 5 cells was added to a 5 mL tube with 5 μL Annexin V-FITC and 5 μL PI. All samples were incubated at room temperature in the dark for 10 min. Cell samples were analyzed by flow cytometry conducted with FACScan (Becton, Dickinson and Company, Franklin, NJ, USA) within 1 h.
Quantitative Real-time PCR
Total RNA of the kidney tissue was extracted with Trizol reagent by following the instructions of the manufacturer. After reverse transcription, complementary DNA was used as template for PCR. Gene expression was detected by RT-qPCR using SYBR Green qPCR Master Mix. Primers for the cytokines and internal reference gene were as follows: TGF-β, forward, 5'-AGGGCTACCATGCCAACTTC-3', reverse, 5'-CCACGTAGTAGACGATGGGC-3'; CollagenIV: forward, 5'-AACAACGTCTGCAACTTCGC-3', reverse, 5'-CTTCACAAACCGCACACCTG-3'; fibronectin: forward, 5'-CCCCAACTGGTTACCCTTCC-3', reverse, 5'-TGTCCGCCTAAAGCATGTT-3'; GAPDH:forward, 5'-GTATGACTCCACTCACGGCAAA-3', reverse, 5'-GGTCTCGCTCCTGGAAGATG-3'. The complete RT-PCR procedure was repeated 3 times.
Mitochondrial membrane potential (ΔΨm) detection
Differentiated podocytes were washed with PBS, incubated with JC-1 (10 mg/mL) at 37 °C for 20 min and washed twice with PBS. Mitochondrial membrane potentials were monitored using a confocal Microscope (Leica DMLB, Wetzlar, Germany). JC-1 monomer fluorescence (green) was observed at 488 nm laser excitations and emissions at 530 nm. JC-1 aggregate fluorescence (red) was observed at 525 nm laser excitations and emissions at 590 nm. Six areas in each cultured dish were scanned and the mean intensity for each region was evaluated. The ratio of JC-1 aggregate to monomer intensity for each region was calculated.
Statistical analysis
All quantified data were expressed as means ± SD. Parameters between two groups were compared by unpaired Student's t-tests. Data involving more than two groups were assessed by analysis of variance (ANOVA). Values of p < 0.05 were considered statistically significant. Statistical analysis was performed using SPSS (Version 18.0 for Windows, SPSS Inc., Chicago, IL, USA).
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Results
Swiprosin-1 expression in mouse glomerular podocytes
As shown in Fig. 1A , swiprosin-1 was expressed in the mouse kidney by immunoblotting. To further study the localization of swiprosin-1 in the kidney, the kidney sections were stained with swiprosin-1 antibody. It was found that swiprosin-1 was widely expressed in mouse glomeruli (Fig. 1B) . In addition, immunofluorescence showed that swiprosin-1 distributed around WT-1 in mouse glomeruli (Fig. 1C) . As WT-1 is a marker of podocytes and expressed in the nucleus [32] [33] [34] , the above results indicate that swiprosin-1 was expressed in podocytes of mouse renal glomeruli. As shown in Fig. 1D , swiprosin-1 was expressed in MPC-5 cells. To unravel the potential function of swiprosin-1 in the kidney, we studied the intracellular localization of swiprosin-1 and found that swiprosin-1 was co-localized with nephrin and mainly localized at the membrane and cytoplasm of differentiated MPC-5 cells by immunofluorescence (Fig. 1E) . Knowing that nephrin is a key protein of the slit diaphragm located at the differentiated podocytes [35] [36] [37] , these results suggest that swiprosin-1 was expressed in podocytes.
Swiprosin-1 expression is up-regulated in diabetic mice and increased in podocytes treated with high glucose
The diabetic mice developed severe albuminuria and presented pathologic changes characteristic of DN such as glomerular hypertrophy and extracellular matrix deposition from 8 weeks after modeling (Fig. 2) . Compared with control group, swiprosin-1 protein level was increased in the renal cortex of the diabetic mice in 8 weeks (Fig. 3A and B) . Similarly, immunofluorescence analysis showed that swiprosin-1 staining was augmented in the diabetic kidney compared with that in control group (Fig. 3C) .
There was no significant difference in swiprosin-1 expression between normal glucose (GS, 5.5 mM) and medium containing mannitol treated MPC-5 podocytes (GS+M group, Fig.  2D ), indicating that the influence of osmotic pressure could be eliminated. The expression of swiprosin-1 was increased in podocytes after stimulation with medium containing glucose at 22 mM (2.18±0.27 ) for 48 h, continuously increased at 33 mM (2.89±0.33), and 44 mM (3.13±0.10) than that in normal glucose (NG, 5.5 mM, 1.00±0.08). Furthermore, there was no significant difference in swiprosin-1 expression in podocytes after stimulation with high glucose (HG, 33 mM, Fig. 2E ) for 12 and 24 h as compared with control group (1.00±1.15). But the expression of swiprosin-1 was increased at 48 h (2.07±0.13) and 72 h (2.35±0.12) and 96h (2.45±0.11).
In addition, the podocyte viability was decreased in 22 mM (0.27±0.02, 
Swiprosin-1 mediates podocyte apoptosis in vivo and in vitro
To investigate the effect of swiprosin-1 in podocytes, we created diabetes models in swiprosin-1 +/+ and swiprosin-1 -/-mice. As shown in Fig. 4A , the immunohistochemistry results revealed that the expression of swiprosin-1 in swiprosin-1 +/+ mice was increased compared with that in swiprosin-1 -/-mice. Compared with diabetic swiprosin-1 +/+ mice, there were some differences in general pathological characteristics, such as body weight reduction, glomerular hypertrophy and ECM accumulation in diabetic swiprosin-1 -/-mice. In addition, diabetic swiprosin-1 -/-mice exhibited a significant increase in serum CST3, and a decrease in kidney/body weight and urinary albumin as compared with those in diabetic swiprosin-1 +/+ mice (Fig. 4) . As shown in Fig. 5A, B Fig. 5D and E) . 
Figure2
Cell
Then we performed in vitro experiments to examine the effects of swiprosin-1 on podocyte apoptosis induced by HG. As shown in Fig. 6A and B, the apoptotic rate of podocytes in CON-HG group was increased sharply by 16.63% as compared with that in Con-NG group (25.64±0.99 vs. 6.34±0.66), as shown by flow cytometry. There was no significant difference in apoptosis level between control podocytes and medium containing mannitol group (M+NG group), indicating that the influence of osmotic pressure on apoptosis level could be eliminated. Also, there was no significant difference in apoptosis level between podocytes transfected with the siRNA knockdown swiprosin-1 and control siRNA treated with NG. However, podocytes with swiprosin-1 knockdown inhibited the increase of the apoptosis rate compared with control siRNA podocytes treated with HG (14.88±1.27 vs. 25.64±0.99).
Furthermore, JC-1 staining of mitochondrial membrane potential (Δψm) showed no significant difference in the red/green fluorescence ratio between control podocytes and medium containing mannitol group (M+NG group), as well as control siRNA group (Fig. 6C and  D) . Compared with control group, the red/green fluorescence ratio in CON-HG group was significantly decreased (1.007±0.06 vs. 0.55±0.05). However, the decrease of the ratio was attenuated in podocytes with swiprosin-1 knockdown compared with that in control siRNA podocytes treated with HG (0.55±0.05 vs. 0.81±0.09).
These data indicate that swiprosin-1 knockdown might contribute to the reduced apoptosis of podocytes in both diabetic mice and MPC-5 cells after HG stimulation.
Deficiency of Swiprosin-1 attenuates podocyte injury in the kidney of diabetic mice
Down-regulation of podocyte-specific proteins is an indicator of podocyte injury [32] . As shown in Fig. 7A, B, C 
Swiprosin-1 induces podocyte mitochondria-dependent apoptosis
There was no significant difference in the level of cleaved-caspase8 between WT-CON and KO-CON groups，as well as swiprosin-1 +/+ control and swiprosin-1 +/+ diabetic group (Fig.  8A) . There was no significant difference in the level of pro-apoptosis proteins (cleavedcaspase3, cleaved-caspase9 and Bax) between WT-CON and KO-CON groups. Compared with swiprosin-1 +/+ control group, cleaved-caspase3, cleaved-caspase9, and Bax protein levels in swiprosin-1 +/+ diabetic mice were increased. Moreover, the expression of pro-apoptosis proteins in swiprosin-1 -/-diabetic mice was lower than that in swiprosin-1 +/+ diabetic mice. Additionally, Bcl-2 protein level was obviously decreased in diabetic swiprosin-1 +/+ mice as compared with that in swiprosin-1 +/+ control mice. Compared with swiprosin-1 +/+ control group, Bcl-2 protein expression was not significantly different in swiprosin-1 -/-control mice. However, the Bcl-2 protein level was increased in swiprosin-1 -/-diabetic mice compared with that in swiprosin-1 +/+ diabetic mice. 
Figure8
As shown in Fig. 8B , there was no significant difference in the level of cleaved-caspase8 between control and HG-treated podocytes, as well as control siRNA tranfected cells and swiprosin-1 knockdown cells (Fig. 8B) . In addition, the expression of active fragments of cleaved-caspase9, cleaved-caspase3, and bax in HG-treated podocytes was higher than that in control cells. However, compared with control siRNA tranfected cells, there was no obvious change in swiprosin-1 knockdown podocytes treated with normal glucose. It was markedly decreased in swiprosin-1 knockdown podocytes compared with that in control siRNA tranfected podocytes after HG stimulation. In addition, Bcl-2 protein expression was decreased in HG treated podocytes compared with that in control siRNA tranfected podocytes treated with NG. But it was increased in HG treated swiprosin-1 knockdown podocytes compared with that in HG treated control siRNA tranfected podocytes. 50±0.01 vs. 1.92±0.24) . Furthermore, we determined the phosphorylation level of p38 in differentiated MPC-5 cells (Fig. 9B) . The phosphorylation level of p38 in HG-treated cells was higher than that in NG-treated cells (2.05±0.07 vs. 1.00±0.14). Phosphorylation p38 expression in swiprosin-1 knockdown podocytes showed no significant difference compared with control siRNA transfected cells after NG. Also, we found that knockdown of swiprosin-1 down-regulated phosphorylation of p38 in podocytes stimulated by HG compared with control siRNA transfected cells stimulated by HG (1.49±0.06 vs. 2.05±0.07).
In addition, p38 was knocked down in podocytes using siRNA (0.34±0.06 vs. 1.00±0.06, Fig. 9C ). As shown in Fig. 9 D and E, the apoptosis level in p38 knockdown podocytes was decreased compared with control siRNA transfected cells after HG stimulation (13.38±1.27 vs. 22.44±1.72). Meanwhile, as shown in Fig. 9 F and G, p38 MAPK inhibitor SB203580 reduced apoptosis from 25.61 % to 15.50 % in high glucose-induced MPC-5 cells, suggesting a role for p38 MAPK in HG-mediated apoptosis (25.61±2.77 vs. 15.50±1.21). Moreover, we constructed full-length swiprosin-1 (LV-Swi) to over-express swiprosin-1 and LV-GFP as control (1.92±0.07 vs. 1.00±0.07, Fig. 9H and I) , and detected the transfection efficiency, which was as high as 94% ( Fig. 9J) . To exclude the effect of HG, apoptosis level was found to be up-regulated in podocytes overexpressed swiprosin-1 compared with control LV-GFP transfected cells (7.84±0.95 vs. 27.16±1.73). Targeted knockdown of p38 attenuated the increase of apoptosis level in podocytes overexpressed swiprosin-1 (16.49±0.73 vs. 27.16±1.73, Fig. 9K and L) .
Discussion
The present study demonstrated that swiprosin-1 was expressed in podocytes of mouse glomeruli and MPC-5 podocyte cells, swiprosin-1 expression was associated with early-stage DN, and swiprosin-1deficiency reduced podocyte apoptosis in diabetic mice and MPC-5 cells induced by HG. In addition, swiprosin-1 could mediate mitochondria-dependent podocyte apoptosis by activating p38 MAPK pathway in early DN.
Previous studies [17, 20, 21] showed that swiprosin-1 was widely accumulated in tissues such as the spleen, lung, liver, heart, and brain in particular. Swiprosin-1 was also expressed in immune cells such as human and primary murine mast cells [14] , murine B cells, T cells [15] [16] [17] , macrophages, natural killer cells [18, 19] , and human peripheral blood mononuclear cells [20] . Protein atlas database indicates that swiprosin-1 is moderately expressed in human renal glomeruli but not tubules (http://www.proteinatlas.org/ENSG00000142634-EFHD2/tissue/kidney#imid_13574299), which is consistent with the finidng of the present study that swiprosin-1 was moderately expressed in podocytes of renal glomeruli. We also demonstrated that swiprosin-1 was expressed in MPC-5 podocytes and mainly located in the membrane and cytoplasm of differentiated podocytes. In addition, our results clearly showed that the expression of swiprosin-1 in the kidney was up-regulated in diabetic mice treated by STZ in vivo, as well as in podocytes treated with HG in vitro. However, podocytes induced by HG decreased cell viability. Podocyte injury is known to play an important role in the development and progression of DN. These results indicate that increased swiprosin-1 in podocytes may be associated with the progression of DN and podocyte damage induced by HG.
It was reported that the Ca 2+ -binding cytoskeletal adaptor protein swiprosin-1 could promote apoptosis in activated B cells [22] . In the murine B cell line WEHI231, overexpression of swiprosin-1 enhanced spontaneous and BCR-induced apoptosis and silencing of swiprosin-1 by shRNA augmented survival of WEHI231 cells and suppressed apoptosis following BCR ligation. Many studies revealed that podocyte apoptosis was one of the important characteristics in early DN [38] [39] [40] [41] [42] . Clinical analysis of kidney specimens from biopsies of patients with diabetes has shown an obvious reduction in the density of podocytes because of apoptosis or detachment, which was evident in patients with early DN even without microalbuminuria [43, 44] . Wu et al. [45] reported that podocytes were depleted in diabetic SD rats treated by a single STZ injection (50 mg/kg) at 4, 8 and 12 weeks, which is the earliest cellular anomaly in DN. Gao et al. [46] . also found that podocyte apoptosis level was up-regulated, the number of podocytes was decreased, and proteinuria was increased in STZ-treated 8-week-old diabetic mice, indicating that podocyte apoptosis is a key step in the development of glomerular disease, which results in proteinuria in early-stage DN. In our study, swiprosin-1 knockdown in MPC-5 cells reduced the apoptosis rate induced by 33 mM HG. Consistently, podocyte apoptosis, podocyte foot process effacement, GBM thickening, urinary albumin, and glomerular hypertrophy were attenuated in diabetic mice with swiprosin-1 deficiency. In addition, nephrin and podocin are two important proteins as components of the podocyte foot process or slit diaphragm complex. In Swiprosin-1 knockout diabetic mice, the expression of nephrin and podocin in renal glomeruli was inhibited, and the upregulation of collagen IV, TGF-β and fibronectin mRNA in the renal cortex was ameliorated. These results indicate that swiprosin-1 knockout could protect podocytes against HG-induced damage. However, whether the protective role of swiprosin-1 in early DN depends on podocytes remains unclear, and therefore swiprosin-1 conditional knockout mouse models are required in future study.
It was also reported that swiprosin-1 may bind to caspase-9 via Ezrin/Radixin/Moesin (ERM) proteins in human H460 non-small lung cancer cells [24] . ERM proteins are crosslinkers between integral membrane proteins and actin filaments, which are also associated with caspase-9, indicating that swiprosin-1 might be involved in caspase-9 dependent apoptosis. Consistent with their results, we found that the expression of cleaved-caspase 9 was attenuated in swiprosin-1 knockout diabetic mice and swiprosin-1 knockdown MPC-5 cells treated with HG, suggesting that swiprosin-1 deficiency may inhibit intrinsic apoptosis of podocytes by activating caspase9 dependent apoptosis. Caspase-8, the major initiator caspase of the death receptor pathway of apoptotic signaling, was unchanged in swiprosin-1 knockout diabetic mice and swiprosin-1 knockdown MPC-5 cells treated with HG, further supporting that swiprosin-1 may induce podocytes apoptosis through the intrinsic apoptotic signaling pathway.
In addition, mitochondria play a critical role in apoptosis by releasing intermembrane space proteins to promote caspase activation [46] [47] [48] [49] . It is the result of losing integrity of the outer mitochondrial membrane caused by proapoptotic members of the Bcl-2 family [36, 49, 50] . It was found in our study that activation of the apoptotic pathway was attenuated due to the decreased level of Bax and increased level of Bcl-2 in swiprosin-1 knockout diabetic mice and swiprosin-1 knockdown MPC-5 cells after HG simulation. The low expression of cleaved caspase3 and 9 indicated the downregulation of podocyte apoptosis because of swiprosin-1 deficiency via the mitochondrial apoptotic pathway induced by hyperglycemia or HG.
Previous studies [22] [23] [24] 51 ] demonstrated that swiprosin-1 was involved in some signaling pathways including NF-κB, protein kinaseC β1/η, protein kinase C-θ and Rho family of small GTPases. P38 MAPK is one of the important members of MAPK [52, 53] . Acting as an integration point for multiple biochemical signals, MAPK participates in a wide variety of cellular processes such as proliferation, differentiation and apoptosis [54] [55] [56] . The p38 MAPK pathway is known to play an important role in podocyte apoptosis [33, 57] . Adhikary et al [58] . reported that greater numbers of phosphorylated p38 cells were observed in the kidney of diabetic patients by immunohistochemistry compared with those in normal humans, indicating that increased p38 MAPK signaling is a feature of diabetic patients. It was demonstrated that the p38 pathway was activated in the renal cortex of STZ-treated 4-week-old diabetic rats with a reduced number of podocytes, established albuminuria and glomerulosclerosis, suggesting that renal cortical p38 activity was increased in early Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry DN, which was correlated with podocyte loss [59] . Sanchez et al. [60] demonstrated that phosphorylation level of p38 MAPK was increased in HG (30 mM)-induced human podocyte apoptosis, and SB203580 (p38 MAPK inhibitor) suppressed podocyte apoptosis induced by HG. Consistent with these studies, our results showed that phosphorylation level of p38 was increased in the renal tissue of diabetic mice and in HG-induced podocytes. Furthermore, treatment with siRNA against p38 MAPK and p38 inhibitor SB203580 reduced apoptosis in HG-induced MPC-5 cells. These findings suggested that p38 MAPK played a role in HGmediated podocyte apoptosis. Moreover, we found that the phosphorylation level of p38 as well as podocyte apoptosis were inhibited in swiprosin-1 knockout diabetic mice and swiprosin-1 knockdown MPC-5 cells treated with HG. These results implied that swiprosin-1 might promote podocyte apoptosis via activation of p38 MAPK signaling pathway. In addition, targeted knockdown of p38 in podocytes inhibited podocyte apoptosis which was promoted by over-expression of swiprosin-1. Therefore, our study suggested that swiprosin-1 might be upstream of p38 MAPK to regulate podocyte apoptosis. However, we cannot draw a conclusion that the increased podocyte apoptosis is totally due to activation of p38 MAPK signaling pathway by swiprosin-1. It was possible that p38 MAPK was activated by not only the increase of swiprosin-1 but also HG in HG-induced podocyte apoptosis. How swiprosin-1 regulates the p38 MAPK signaling pathway in podocyte apoptosis in early-stage DN needs further investigation.
Conclusion
We found that upregulation of swiprosin-1 in early DN promoted mitochondriadependent podocyte apoptosis by activating p38 MAPK signaling pathway. This finding highlights the important role of swiprosin-1 in podocyte apoptosis. It seems reasonable to suggest that the development and application of swiprosin-1 inhibitors may be a new target for the treatment of DN patients, especially in the early stage.
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